LON:OXB - Oxford BioMedica Stock Price, News & Analysis

GBX 644
-1.00 (-0.16 %)
(As of 08/19/2019 04:00 PM ET)
Today's Range
635
Now: GBX 644
680
50-Day Range
644
MA: GBX 690.39
730
52-Week Range
581
Now: GBX 644
930
Volume81,302 shs
Average Volume6.89 million shs
Market Capitalization£494.39 million
P/E Ratio59.08
Dividend YieldN/A
BetaN/A
Oxford BioMedica plc, a biopharmaceutical company, engages in the research, development, and bioprocessing of lentiviral vector and cell therapy products for the treatment of various cancers, Parkinson's, central nervous system disorders, and ocular conditions in Europe and internationally. The company operates through Platform and Product segments. Read More…

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-1865-783000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£66.78 million
Cash FlowGBX 48.72 per share
Book ValueGBX 52.60 per share

Profitability

Miscellaneous

Employees432
Market Cap£494.39 million
Next Earnings Date9/4/2019 (Estimated)
OptionableNot Optionable

Receive OXB News and Ratings via Email

Sign-up to receive the latest news and ratings for OXB and its competitors with MarketBeat's FREE daily newsletter.


Oxford BioMedica (LON:OXB) Frequently Asked Questions

What is Oxford BioMedica's stock symbol?

Oxford BioMedica trades on the London Stock Exchange (LON) under the ticker symbol "OXB."

When is Oxford BioMedica's next earnings date?

Oxford BioMedica is scheduled to release their next quarterly earnings announcement on Wednesday, September 4th 2019. View Earnings Estimates for Oxford BioMedica.

What is the consensus analysts' recommendation for Oxford BioMedica?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Oxford BioMedica in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Oxford BioMedica.

Has Oxford BioMedica been receiving favorable news coverage?

News coverage about OXB stock has trended negative this week, according to InfoTrie. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Oxford BioMedica earned a news sentiment score of -2.3 on InfoTrie's scale. They also assigned media stories about the biopharmaceutical company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Oxford BioMedica.

Who are some of Oxford BioMedica's key competitors?

What other stocks do shareholders of Oxford BioMedica own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioMedica investors own include Enquest (ENQ), Petra Diamonds (PDL), Sirius Minerals (SXX), Centamin (CEY), Lloyds Banking Group (LLOY), Afren (AFR), Premier Oil (PMO), Barclays (BARC), Genel Energy (GENL) and Andalas Energy and Power (ADL).

Who are Oxford BioMedica's key executives?

Oxford BioMedica's management team includes the folowing people:
  • Mr. John Dawson, CEO & Exec. Director (Age 59)
  • Mr. Stuart Paynter, CFO & Director
  • Mr. Timothy William Watts, Exec. Officer (Age 61)
  • Mr. Peter Nolan, Consultant (Age 66)
  • Mr. Nick Page, Chief Operations Officer

How do I buy shares of Oxford BioMedica?

Shares of OXB and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Oxford BioMedica's stock price today?

One share of OXB stock can currently be purchased for approximately GBX 644.

How big of a company is Oxford BioMedica?

Oxford BioMedica has a market capitalization of £494.39 million and generates £66.78 million in revenue each year. Oxford BioMedica employs 432 workers across the globe.View Additional Information About Oxford BioMedica.

What is Oxford BioMedica's official website?

The official website for Oxford BioMedica is http://www.oxfordbiomedica.co.uk/.

How can I contact Oxford BioMedica?

Oxford BioMedica's mailing address is Windrush Court, Transport Way, OXFORD, OX4 6LT, United Kingdom. The biopharmaceutical company can be reached via phone at +44-1865-783000.


MarketBeat Community Rating for Oxford BioMedica (LON OXB)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  264 (Vote Outperform)
Underperform Votes:  312 (Vote Underperform)
Total Votes:  576
MarketBeat's community ratings are surveys of what our community members think about Oxford BioMedica and other stocks. Vote "Outperform" if you believe OXB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OXB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/19/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel